Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of adipotide injection in China. Welcome to wholesale bulk high quality adipotide injection for sale here from our factory. Good service and reasonable price are available.
Adipotide Injection presents an unconventional application in xenotransplantation research, where its selective vascular targeting mechanism is being explored to mitigate fat-associated immune rejection in grafted tissues. By precisely disrupting the vasculature of adipose deposits surrounding transplanted organs in preclinical models, this peptide reduces the lipid-rich microenvironment that often exacerbates inflammatory responses and graft failure. Interestingly, studies in porcine-to-primate transplantation trials suggest that localized Adipotide administration may decrease macrophage infiltration by destabilizing the perivascular fat niche, a lesser-known contributor to xenograft fibrosis. Beyond transplantation, its cryopreservation potential is under investigation-preliminary data indicate that pretreatment with Adipotide could improve the viability of adipocyte-rich tissues (e.g., mammary glands in livestock breeding) by minimizing ice crystal-induced vascular damage during freezing cycles. Additionally, its ecotoxicological shadow remains uncharacterized: metabolites of degraded Adipotide in veterinary wastewater may interact with aquatic organisms' lipid metabolism pathways, analogous to endocrine disruptors. A niche but provocative hypothesis posits that its prohibitin-binding affinity could be repurposed to control invasive species with fat-dependent reproductive cycles (e.g., jellyfish blooms), though unintended trophic cascade risks loom. These oblique applications underscore Adipotide's latent versatility beyond metabolic manipulation.
|
|
|
Adipotide Powder COA
It is a synthetic polypeptide. Its chemical properties determine its mechanism of action and biological activity as a vascular-targeting drug. The following analysis is conducted from four aspects: molecular structure, receptor binding characteristics, stereoscopic chemical conformation, and stability.
Molecular Structure: Precise Design of Peptide Analogues
The molecular sequence of Adipotide is CKGGRAKDC-GG-D(KLAKLAK)₂, which belongs to peptide analogues (peptidomimetics). Its structure can be decomposed into three functional modules:
Targeting Module (CKGGRAKDC)
This sequence was obtained through phage display technology and has a high affinity for the prohibitin receptor on the surface of adipose tissue vascular endothelial cells. Prohibitin is a transmembrane protein that is highly expressed in white adipose tissue vessels and less expressed in other tissues, providing a molecular basis for the targeting of Adipotide.
Linking Module (GG)
Composed of two glycine (Glycine) residues, it serves as a flexible linker to connect the targeting module with the killing module, reducing spatial steric hindrance and ensuring that both modules can independently perform their functions.
Killing Module (D(KLAKLAK)₂)
This sequence is composed of two repeated D-type amino acids (D-Lys-D-Leu-D-Ala-D-Lys-D-Leu-D-Ala), and the D conformation is more stable compared to the natural L conformation, which can resist protease degradation. Its mechanism of action is to penetrate the mitochondrial membrane, induce mitochondrial swelling, membrane potential collapse, and release of cytochrome c, ultimately triggering caspase-3/7-dependent cell apoptosis.
Receptor Binding Characteristics: Dual Receptor Cooperative Targeting Mechanism
It enhances targeting and biological activity by simultaneously binding to two receptors:
Prohibitin receptor
It is mainly expressed in the vascular endothelial cells of white adipose tissue and is the main target of Adipotide. After binding, it enters the cells through endocytosis, and its killing module directly acts on mitochondria, inducing endothelial cell apoptosis.
ANXA2 receptor
It is also expressed in the fat tissue vessels and works synergistically with the prohibitin receptor. ANXA2 (Annexin A2) participates in cell membrane repair and signal transduction. After Adipotide binds, it may interfere with its function, further amplifying the apoptotic signal of endothelial cells.
The biological significance of dual receptor binding:
Enhanced targeting: The two receptors are co-expressed in the blood vessels of adipose tissue but are expressed at low levels in other tissues, reducing off-target effects.
Improved affinity: The binding of the dual receptors forms a multivalent interaction, significantly enhancing the binding strength of Adipotide to vascular endothelial cells.
Synergistic killing: Through different signaling pathways (such as the mitochondrial apoptosis pathway and the membrane repair pathway), it synergistically induces endothelial cell death.
Stereoscopic chemical conformation: 3D structure determines functional specificity
The biological activity of Adipotide depends on its specific stereoscopic chemical conformation:
The balance between α-helix and β-sheet
Molecular dynamics simulations show that exhibits a dynamic conformation in solution. Its targeting module (CKGGRAKDC) tends to form an α-helix, while the killing module (D(KLAKLAK)₂) mainly adopts a β-sheet structure. This conformational balance enables it to both bind to the receptor through an α-helix and penetrate the cell membrane and mitochondrial membrane through a β-sheet.
The rigid conformation of D-type amino acids
The D-type amino acids in the killing module, due to their side chain orientation being opposite to that of L-type, form a more stable β-sheet structure, resisting protease degradation and prolonging the in vivo half-life. Experiments have shown that the half-life of the D-type killing module is 3-5 times that of the L-type homolog.
The stabilizing effect of disulfide bonds
The molecule contains a disulfide bond (Cys-Cys) that connects the targeting module and the linker module, fixing their spatial conformation and preventing the decrease in receptor binding ability due to conformational fluctuations.
Stability: Chemical Modification and Formulation Optimization
The stability of Adipotide is affected by multiple factors and requires chemical modification and formulation design to ensure its bioavailability:
Resistance to proteases
The presence of D-type amino acids and disulfide bonds significantly enhances the resistance of Adipotide to proteases. In an in vitro simulation of gastric juice experiment, the degradation half-life exceeds 24 hours, while the unmodified L-type homologues only lasts for 2 hours.
Solubility and formulation compatibility
It is a amphiphilic molecule, with its targeting module being hydrophilic and the killing module being hydrophobic. To improve solubility, it is often formulated in an acetate form (Adipotide acetate), where the acetate ion shields the hydrophobic region, increasing its solubility in physiological saline to above 10 mg/mL.
Storage stability
At -20℃, it can be stably stored for more than 2 years; the solution after reconstitution should be stored at 4℃ and used within 72 hours to avoid loss of activity due to conformational changes.
Ecological exposure pathways and potential distribution
Adipotide injection, as a peptide analog targeting the blood vessels of adipose tissue, its ecological exposure pathway and potential distribution should be comprehensively analyzed from multiple dimensions such as the drug's properties, environmental release, migration and transformation, and biological accumulation.
The core structure of Adipotide is a bifunctional peptide, which is formed by linking the targeting sequence CKGGRAKDC and the killing sequence D(KLAKLAK)₂ through a glycine linker (GG). Its molecular weight is approximately 2.5 kDa, and it contains D-type amino acids (such as D-Lys, D-Ala), significantly enhancing its resistance to proteases and prolonging the persistence of the drug in the environment. This characteristic makes it less prone to degradation after entering the environment, providing a basis for long-term ecological exposure.
Main pathways of ecological exposure
Medical wastewater discharge
The wastewater from hospitals and clinics is the main pathway for Adipotide to enter the aquatic ecosystem. After patients use the medication, the unmetabolized drug and its metabolites may be excreted through urine or feces and enter the wastewater treatment system. However, the stability of Adipotide may prevent it from being completely degraded during the wastewater treatment process, especially under low temperatures or low pH conditions, where the degradation rate further slows down. Therefore, some of the drug may be discharged along with the treated wastewater into natural water bodies such as rivers and lakes.
Pharmaceutical production waste
During the production of Adipotide, waste liquid and waste residue containing drug residues may be generated. If these wastes are not properly treated (such as harmless incineration or chemical degradation), they may contaminate groundwater through surface runoff or soil seepage. For example, the soil around the production facilities may become a "source area" for drug accumulation due to long-term contact with drug-containing wastewater, and the drug may then spread to wider areas through groundwater flow.
Animal experiment waste
The excreta of non-human primates (such as rhesus monkeys) used in preclinical studies may contain Adipotide. If these excreta are directly discharged without proper harmless treatment (such as being used as fertilizer for farmland), the drug may enter the water body through soil infiltration or surface runoff. This may expand the scope of ecological exposure.
Potential distribution and environmental migration
Water body distribution
After Adipotide enters water bodies, it may enter the cells of aquatic organisms through passive diffusion due to its small molecular weight and certain lipophilicity. Its distribution is affected by factors such as water flow, temperature, and pH value. For example, in still water environments (such as lakes), the drug may accumulate in the sediment due to sedimentation; while in flowing water bodies (such as rivers), the drug may migrate downstream with the water flow.
Soil and groundwater distribution
If Adipotide injection enters the soil through waste leakage or irrigation, its lipophilicity may promote its adsorption in soil organic matter, but the stability of D-type amino acids may lead to long-term drug residue. In addition, the drug may pollute groundwater through rainwater infiltration, especially in sandy soil or rock layers with fissures, where the groundwater flow is fast, and the range of drug migration may be wider.
Bioaccumulation and food chain transfer
The ecological risk also involves its accumulation in organisms. The gills and skin of aquatic organisms (such as fish, invertebrates) are its main absorption pathways, and top predators (such as carnivorous fish, birds) may accumulate higher concentrations of the drug through the food chain. For example, after plankton absorb the drug, it is taken by small fish, and the drug accumulates in their bodies; small fish are then preyed upon by large fish, and the drug concentration further increases, forming a "biological amplification" effect.
Uncertainty of ecological risk
Although the pathways of ecological exposure and potential distribution of Adipotide have been preliminarily clarified, its ecological risk still remains uncertain:
Toxicity of degradation products
The degradation products of Adipotide in the environment may have different toxicity from the parent compound. Further research is needed to study its degradation pathways and the ecological impact of the products.
Species differences
Different organisms may have significant differences in their sensitivity to Adipotide. For example, fish may absorb more of the drug due to their large gill surface area, while amphibians may face a greater risk due to their high skin permeability.
Long-term low-dose exposure effects
Current research mainly focuses on acute toxicity, while long-term low-dose exposure may have hidden effects on biological reproduction, behavior, or ecosystem functions. Long-term monitoring studies need to be conducted.
Frequently Asked Questions
What is the other name?
+
-
Adipotide, also known as FTPP (Fat-Targeted Proapoptotic Peptide), is a synthetic peptidomimetic compound designed to induce apoptosis in the vasculature of white adipose tissue selectively.
Are there downsides to taking peptides?
+
-
The downsides of peptides include potential side effects like headaches, fatigue, nausea, and injection site reactions; risks from unregulated sources such as contamination and incorrect dosing; and potential hormonal imbalances or organ strain, with unknown long-term effects for many experimental peptides. Quality and sourcing issues are significant, as many aren't FDA-approved, leading to potential health dangers from impurities or mislabeling, despite online hype.
Who should avoid peptides?
+
-
People who are pregnant, breastfeeding, have cancer, kidney issues, or uncontrolled hormonal conditions, or are taking certain medications (like corticosteroids) should avoid unprescribed or unregulated peptides, as well as those with a history of heart problems or blood clots, due to risks of hormonal imbalance, potential cancer cell stimulation, unknown long-term effects, contamination, and serious side effects like muscle damage or diabetes, emphasizing that only a doctor should guide peptide use.
What foods are high in peptides?
+
-
Peptide-rich foods are primarily high-protein sources like meat, fish, eggs, and dairy, but also include legumes (beans, lentils, soy), nuts, seeds (flax, hemp), and whole grains (oats), as peptides are chains of amino acids. Key examples include fish (salmon, tuna), poultry, soy products (tofu, edamame), milk, yogurt, and beans, providing building blocks for collagen and supporting various bodily functions.
Hot Tags: adipotide injection, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale